Free Trial
NASDAQ:EVLO

Evelo Biosciences (EVLO) Stock Price, News & Analysis

Evelo Biosciences logo
$0.0003 0.00 (-40.00%)
As of 05/2/2025 09:57 AM Eastern

About Evelo Biosciences Stock (NASDAQ:EVLO)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.00
$0.06
Volume
8,972 shs
Average Volume
10,994 shs
Market Capitalization
$5,694.90
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Receive EVLO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

EVLO Stock News Headlines

Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO)
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Evelo Biosciences, Inc. (EVLO)
See More Headlines

EVLO Stock Analysis - Frequently Asked Questions

Evelo Biosciences' stock was trading at $0.0005 at the start of the year. Since then, EVLO shares have decreased by 40.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Evelo Biosciences, Inc. (NASDAQ:EVLO) released its quarterly earnings data on Wednesday, October, 27th. The company reported ($12.60) EPS for the quarter, missing the consensus estimate of ($10.80) by $1.80.

Evelo Biosciences shares reverse split on the morning of Friday, June 30th 2023. The 1-20 reverse split was announced on Friday, June 30th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Evelo Biosciences (EVLO) raised $85 million in an IPO on Wednesday, May 9th 2018. The company issued 5,300,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Cowen and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

Shares of EVLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evelo Biosciences investors own include Sangamo Therapeutics (SGMO), Fulcrum Therapeutics (FULC), CymaBay Therapeutics (CBAY), Provention Bio (PRVB), VIVUS (VVUS), Meta Platforms (META) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
10/27/2021
Today
5/03/2025
Next Earnings (Estimated)
6/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:EVLO
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
18,789,000
Market Cap
$5,694.90
Optionable
No Data
Beta
1.05
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:EVLO) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners